Estrella Immunopharma
(NASDAQ) ESLA
Estrella Immunopharma Financials at a Glance
Market Cap
$43.72M
Revenue (TTM)
$0.00
Net Income (TTM)
$13.06M
EPS (TTM)
$-0.36
P/E Ratio
-2.91
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.02
Volume
134,236
Open
$1.07
Price
$1.02
Volume
134,236
Open
$1.07
Previous Close
$1.04
Daily Range
$1.00 - $1.18
52-Week Range
$0.73 - $3.15
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.02
Volume
134,236
Open
$1.07
Previous Close
$1.04
Daily Range
$1.00 - $1.18
52-Week Range
$0.73 - $3.15
ESLA News
ESLA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Estrella Immunopharma
Industry
Biotechnology
Sector
Health CareCEO
Cheng Liu, PhD
Website
www.estrellabio.comHeadquarters
EmeryVille, CA 94608, US
ESLA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-315%
Return on Capital
1%
Return on Assets
-4%
Earnings Yield
-34.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.72M
Shares Outstanding
42.03M
Volume
134.24K
Short Interest
0.00%
Avg. Volume
173.87K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$13.06M
EBITDA
$13.06M
Operating Cash Flow
$1.79M
Capital Expenditure
$0.00
Free Cash Flow
$1.79M
Cash & ST Invst.
$1.38M
Total Debt
$0.00
Estrella Immunopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$43.72M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$613.17K
+41.6%
EBITDA
$613.20K
+41.6%
Quarterly Fundamentals
Net Cash
$1.38M
+51.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-4.11%
N/A
Return on Invested Capital
1.26%
N/A
Free Cash Flow
$727.33K
+67.2%
Operating Cash Flow
$727.33K
+67.2%